Multiple Myeloma Clinical Trials in San Antonio, Texas

5 studies are recruiting for multiple myeloma in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

    The purpose of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple myeloma.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute, San Antonio, Texas
    Locations
    52 in total
    Run by
    Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

    See if you can join NCT06297226 on ClinicalTrials.gov

  2. A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

    The purpose of this study is to evaluate how well JNJ-79635322 works when compared with an anti-B-cell maturation antigen (BCMA)xCD3 bispecific antibody.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Texas Transplant Institute, San Antonio, Texas
    Locations
    144 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07258511 on ClinicalTrials.gov

  3. A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

    This is a Phase 2, open-label, single-arm, multicenter study to assess the antimyeloma activity and further characterize the safety, tolerability, PK, and PD of cemsidomide in combination with dexamethasone in participants with relapsed/refractory multiple myeloma (r/r MM).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    START San Antonio, San Antonio, Texas
    Locations
    21 in total
    Run by
    C4 Therapeutics, Inc.

    See if you can join NCT07284758 on ClinicalTrials.gov

  4. Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

    This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Texas Oncology - San Antonio, San Antonio, Texas
    Locations
    17 in total
    Run by
    SCRI Development Innovations, LLC

    See if you can join NCT05972135 on ClinicalTrials.gov

  5. A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

    The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd in participants with TI-NDMM.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    GSK Investigational Site, San Antonio, Texas
    Locations
    181 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06679101 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.